These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 29248133)

  • 21. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.
    Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Secades P; Bernaldo-de-Quirós S; Rodrigo JP; Astudillo A; Chiara MD
    Oncotarget; 2017 Feb; 8(8):13730-13746. PubMed ID: 28099149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
    Kim Y; Choi JW; Lee JH; Kim YS
    Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4.
    Pinheiro C; Miranda-Gonçalves V; Longatto-Filho A; Vicente AL; Berardinelli GN; Scapulatempo-Neto C; Costa RF; Viana CR; Reis RM; Baltazar F; Vazquez VL
    Cell Cycle; 2016 Jun; 15(11):1462-70. PubMed ID: 27105345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis.
    Sheng G; Gao Y; Wu H; Liu Y; Yang Y
    J Orthop Surg Res; 2023 Feb; 18(1):131. PubMed ID: 36814318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial metabolism in cancer metastasis: visualizing tumor cell mitochondria and the "reverse Warburg effect" in positive lymph node tissue.
    Sotgia F; Whitaker-Menezes D; Martinez-Outschoorn UE; Flomenberg N; Birbe RC; Witkiewicz AK; Howell A; Philp NJ; Pestell RG; Lisanti MP
    Cell Cycle; 2012 Apr; 11(7):1445-54. PubMed ID: 22395432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers.
    Witkiewicz AK; Whitaker-Menezes D; Dasgupta A; Philp NJ; Lin Z; Gandara R; Sneddon S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Mar; 11(6):1108-17. PubMed ID: 22313602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of streptozotocin-induced diabetes on markers of skeletal muscle metabolism and monocarboxylate transporter 1 to monocarboxylate transporter 4 transporters.
    Py G; Lambert K; Milhavet O; Eydoux N; Préfaut C; Mercier J
    Metabolism; 2002 Jul; 51(7):807-13. PubMed ID: 12077722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer.
    Polański R; Hodgkinson CL; Fusi A; Nonaka D; Priest L; Kelly P; Trapani F; Bishop PW; White A; Critchlow SE; Smith PD; Blackhall F; Dive C; Morrow CJ
    Clin Cancer Res; 2014 Feb; 20(4):926-937. PubMed ID: 24277449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicompartment metabolism in papillary thyroid cancer.
    Curry JM; Tassone P; Cotzia P; Sprandio J; Luginbuhl A; Cognetti DM; Mollaee M; Domingo M; Pribitkin EA; Keane WM; Zhan TT; Birbe R; Tuluc M; Martinez-Outschoorn U
    Laryngoscope; 2016 Oct; 126(10):2410-2418. PubMed ID: 26666958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone increases lactate transport, monocarboxylate transporter (MCT) 1 and MCT4 in rat skeletal muscle.
    Enoki T; Yoshida Y; Lally J; Hatta H; Bonen A
    J Physiol; 2006 Nov; 577(Pt 1):433-43. PubMed ID: 16959859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical analysis of MCT1, MCT2 and MCT4 expression in rat plantaris muscle.
    Hashimoto T; Masuda S; Taguchi S; Brooks GA
    J Physiol; 2005 Aug; 567(Pt 1):121-9. PubMed ID: 15932892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
    Doyen J; Trastour C; Ettore F; Peyrottes I; Toussant N; Gal J; Ilc K; Roux D; Parks SK; Ferrero JM; Pouysségur J
    Biochem Biophys Res Commun; 2014 Aug; 451(1):54-61. PubMed ID: 25058459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration.
    De Saedeleer CJ; Porporato PE; Copetti T; Pérez-Escuredo J; Payen VL; Brisson L; Feron O; Sonveaux P
    Oncogene; 2014 Jul; 33(31):4060-8. PubMed ID: 24166504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Programmed death 1 expression in the peritumoral microenvironment is associated with a poorer prognosis in classical Hodgkin lymphoma.
    Koh YW; Jeon YK; Yoon DH; Suh C; Huh J
    Tumour Biol; 2016 Jun; 37(6):7507-14. PubMed ID: 26678894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma.
    Solórzano JL; Menéndez V; Parra E; Solis L; Salazar R; García-Cosío M; Climent F; Fernández S; Díaz E; Francisco-Cruz A; Khoury J; Jiang M; Tamegnon A; Montalbán C; Melero I; Wistuba I; De Andrea C; F García J
    Oncoimmunology; 2024; 13(1):2388304. PubMed ID: 39135889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report).
    Dell'Anno I; Barone E; Mutti L; Rassl DM; Marciniak SJ; Silvestri R; Landi S; Gemignani F
    J Transl Med; 2020 Sep; 18(1):341. PubMed ID: 32887638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: Implications for immune dysregulation, prognosis and potential therapeutic targeting.
    Quesada AE; Assylbekova B; Jabcuga CE; Zhang R; Covinsky M; Rios A; Nguyen ND; Brown RE
    Int J Clin Exp Pathol; 2015; 8(10):13241-8. PubMed ID: 26722524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma.
    Huhta H; Helminen O; Palomäki S; Kauppila JH; Saarnio J; Lehenkari PP; Karttunen TJ
    Oncotarget; 2017 Apr; 8(14):22894-22902. PubMed ID: 28206968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL.
    Vari F; Arpon D; Keane C; Hertzberg MS; Talaulikar D; Jain S; Cui Q; Han E; Tobin J; Bird R; Cross D; Hernandez A; Gould C; Birch S; Gandhi MK
    Blood; 2018 Apr; 131(16):1809-1819. PubMed ID: 29449276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development.
    Wilde L; Roche M; Domingo-Vidal M; Tanson K; Philp N; Curry J; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):198-203. PubMed ID: 29248131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.